NCT02813642View on ClinicalTrials.gov

Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 8, 2011

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
Chronic Kidney Disease
Interventions
BIOLOGICAL

Plasma osteoprotegerin level

dosage of plasma osteoprotegerin

BIOLOGICAL

Plasma fibroblast growth factor 23 level

dosage of plasma fibroblast growth factor 23

PROCEDURE

Vascular calcification score

measurement of vascular calcification score by X-ray of the lateral abdominal aorta

Trial Locations (5)

Unknown

RECRUITING

Centre Hémodialyse du Lez, Castelnau-le-Lez

RECRUITING

AIDER, Montpellier

RECRUITING

CHU Montpellier, Nephrology department, Montpellier

RECRUITING

CH Nimes, Nephrology department, Nîmes

RECRUITING

CH Perpignan, Nephrology department, Perpignan

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02813642 - Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients | Biotech Hunter | Biotech Hunter